Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multi-centre versus single-centre trials in migraine.

C Hedman1, A R Andersen, J Olesen

  • 1Medical Department, AB Hässle, Mölndal, Sweden.

Neuroepidemiology
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer in young adulthood - classifying the intensity of treatment.

Acta oncologica (Stockholm, Sweden)·2022
Same author

Systematic review and meta-analysis of the effect of pertussis vaccine in pregnancy on the risk of chorioamnionitis, non-pertussis infectious diseases and other adverse pregnancy outcomes.

Vaccine·2021
Same author

Changes in the heart silhouette as studied by angiocardiography.

The Journal of the Faculty of Radiologists. Faculty of Radiologists (Great Britain)·2014
Same author

Carbachol induces headache, but not migraine-like attacks, in patients with migraine without aura.

Cephalalgia : an international journal of headache·2009
Same author

Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs.

Cephalalgia : an international journal of headache·2009
Same author

Delayed migraine-like headache in healthy volunteers after a combination of acetazolamide and glyceryl trinitrate.

Cephalalgia : an international journal of headache·2009
Same journal

Temporal trends in incidence and nationwide estimates of first-ever arterial stroke in children: Dijon Stroke Registry (1985-2025).

Neuroepidemiology·2026
Same journal

Changing Referral Patterns in Paediatric Neurology: A Tertiary Outpatient Study within Brazil's Unified Health System, 2014-2024.

Neuroepidemiology·2026
Same journal

Diverging trajectories of multiple sclerosis burden in postmenopausal women across East Asia: a comparative analysis of China, Japan, and the Republic of Korea from 1990 to 2050.

Neuroepidemiology·2026
Same journal

Sex-Specific Modifiable Factors for Incident Late-Onset Dementia in the Geographic Context: A Longitudinal Comparative Analysis of Multicohort Studies across 19 Countries.

Neuroepidemiology·2026
Same journal

Global prevalence of epilepsy and temporal trends, 1980-2025: a systematic review and meta-analysis.

Neuroepidemiology·2026
Same journal

Neurobrucellosis: A Narrative Review.

Neuroepidemiology·2026
See all related articles

For migraine clinical trials, single-centre designs are generally preferred for methodological rigor. Multi-centre designs are used when patient recruitment is challenging, offering broader population representation.

Area of Science:

  • Clinical Trials Methodology
  • Neurology Research
  • Migraine Studies

Background:

  • Migraine clinical trials frequently require multi-centre participation, introducing methodological complexities.
  • Evaluating different clinical trial designs is crucial for optimizing research quality and patient recruitment.

Purpose of the Study:

  • To compare the methodological strengths and weaknesses of single-centre versus multi-centre migraine trial designs.
  • To discuss the utility and limitations of multiple-independent trials (MIT) in migraine research.

Main Methods:

  • Comparative analysis of single-centre and multi-centre trial methodologies.
  • Discussion of the advantages and disadvantages of each design in the context of migraine research.
  • Evaluation of the role of multiple-independent trials (MIT) for data synthesis.

Related Experiment Videos

Main Results:

  • Single-centre designs are methodologically superior for migraine trials.
  • Multi-centre designs facilitate patient recruitment and enhance population representativeness.
  • Multiple-independent trials offer value for summarizing diverse data, particularly for side effect evaluation.

Conclusions:

  • Prioritize single-centre designs for migraine studies whenever feasible due to methodological advantages.
  • Employ multi-centre designs when necessary for adequate patient accrual and generalizability.
  • Consider multiple-independent trials as a supplementary approach for comprehensive data analysis, especially for safety outcomes.